CD40LG and Zika virus infectious disease: This is why human clinical trials do not require evidence of ZIKV RNA in infant body fluids or ZIKV-specific IgM to enroll infants into studies characterizing the long term outcomes of children born to women with documented or suspected ZIKV infection during pregnancy.